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Factors Affecting Adrenocortical Hormone
Function
by E. Brad Thompson*
This paper will briefly outline those elements which must be considered in assessing the
effects of any given compound which might impinge on the actions of adrencortical steroids.
Considerations that ought to be taken into account include the following: the delivery to the
affected cells ofcortiocosteroids, the uptake ofthe hormone by the cells, the metabolism ofthe
hormone by the cells, the intracellular actions of the hormone, the possible secondary
interactions between cells, and multihormonal actions on the final target cell.
Delivery of Corticosteroids to
Target Tissues
The astute reader will already have noted that by
beginning with the question ofhormone delivery, I
have neglected synthesis and its regulation. I have
done so because synthesis seems outside the topic
of factors affecting corticosteroid function, though
ofcourse the ultimate behavior ofhormone-sensitive
tissues depends on accurate control of hormone
synthesis. For a consideration ofthis important and
complex topic, therefore, the reader is referred to
standard works on the subject. The most important
concept regarding circulating corticosteroids is that
they circulate in at least two physical forms: as free
steroids dissolved in the aqueous phase of plasma,
and as complexes adsorbed to serum proteins. Most
natural cortiocosteroids in fact do so in the bound
form. Corticosteroid binding globulin (CBG) is a
highly specific binder for this class of steroids, and
the naturally occurring members of the class, and
some synthetic analogs bind to CBG with high
affinity (1). But corticosteroids also bind, with less
specificity and affinity, to a number of plasma
proteins. Because ofits high plasma concentration,
albumin represents a major adsorbent for circulat-
ing steroids. Thus about 10% of circulating corti-
costeroids are free and about 90% are bound.
Evidence in tissue culture systems strongly sug-
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gests that it is the free steroid which acts upon
target cells (2-5). This evidence includes the follow-
ing points, obtained from our studies in a cultured
line ofrat hepatoma cells (HTC cells) which express
the classic glucocorticoid-induced enzyme tyrosine
aminotransferase. This enzyme can be induced in
these cells either in serum-containing medium or in
defined medium from which all proteins have been
removed (2, 3). In fact, if limiting quantities ofthe
inducing steroid are added to the cells, CBG and
CBG-containing sera can be shown to reduce the
extent ofenzyme induction, presumably by binding
aportion ofthe steroid in aform not available to the
cells (4). Furthermore, the added potency ofcertain
synthetic steroids can be partially explained by
their lack of binding to CBG as a result ofwhich, a
higher concentration of free steroid reaches the
target cell. On the other hand, the large pool of
circulating, bound, native steroids may provide a
relatively stable supply of hormone, damping out
large and rapid variations in free steroid concentra-
tion and thus ensuring a modulated tissue response
(1, 6). The obvious consequence of these consider-
ations is that any substance altering the dynamics
of the cardiovascular system or the synthesis and
turnover ofthe serum proteins may alter the tissue
content of free steroid and therefore steroid-
mediated cellular activities. Such alterations would
be predicted to be most marked following acute
changes in the above parameters, since chronic
alterations in free steroid concentration would
eventually be compensated for by adjustments in
synthesis and excretion.
99Cell Uptake and Metabolism of
Corticosteroids
Most experts in the field believe that cell uptake
of steroids is a passive process (1). Free steroid in
the tissue space is thought to dissolve in the plasma
membrane and then to reappear in the cytoplasm,
due to its tight binding to a specific receptor (of
which, more below). Harrison, however, has pre-
sented data in one cell system at least which
suggests that uptake is an active, energy-requiring
process (1). In my opinion, the question of cell
uptake of steroids is underinvestigated. In any
case, alterations of target cell membranes by toxic
chemicals could produce changes affecting steroid
uptake.
Metabolism of glucocorticoids is rarely if ever
required to produce an active intracellular com-
pound. Much data indicate that in most cells active
glucocorticoids produce their responses without
alterations in other structures. However, cortico-
steroid metabolism to less active forms may play a
critical role in determining the tissue effects ofthe
hormone. A clear example of this is found in the
work of Santen et al. (7, 8). These workers were
interested in testing the effects ofaminoglutethim-
ide to bring about a "medical adrenalectomy" for
the treatment of breast cancer. The goal was to
eliminate adrenal-derived estrogens, and of course
it was necessary to provide replacement glucocor-
ticoids for the patients, since the blockerinhibits all
steroid synthesis. Initially dexamethasone was cho-
sen as the replacement. This is a highly potent
glucocorticoid, not normally metabolized to less
active form(s). But in the aminoglutethimide-
treated individuals, it was found that dexametha-
sone was metabolized/excreted and was therefore
ineffective in replacement therapy. In fact the
natural glucocorticoid, cortisol, actually provided
better replacement therapy. The conclusion which
must be drawn from this example is that not only
may normal metabolism and/or excretion ofcortico-
steroids be altered by unusual compounds, but also
that unexpected metabolic paths may be induced,
grossly changing the actions of the natural or
synthetic adrenal steroids.
Intracellular Actions of
Corticosteroids
The initial intracellular interaction between ste-
roid and cell elements is that ofbinding to receptor.
These receptors are proteins specific for each class
of steroid. Thus the receptors for corticosteroids
are proteins of80-100,000 daltons, highly sensitive
to thiol oxidants, and having one high-affinity
glucocorticoid binding site permolecule (9). In most
systems studied, the affinity for potent glucocortic-
oids (expressed as apparent equilibrium dissocia-
tion constant) is Kd- 10-9-108M. Occupancy of
these proteins by steroid correlates well with
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FIGURE 1. Generalized modelforsteroid hormone action. Steroidfreely enterscell, where it combines with
free receptor, R, to make initial steroid-receptor complex, SR. The complex undergoes activation to the
SR* forn, which binds in the nucleus due to increased affinity for DNA/chromatin. The nuclearcomplex,
NR results in alterations in RNA synthesis and therefore in altered cellular enzymes, etc. This simple
model does not explain differentiated cellular responses to a specific steroid but some possibilities are
pointed out in Figure 2.
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affinity predicts well the relative potencies ofmost
steroids. Historically, the receptor concept as ap-
plied to steroids developed from observing concen-
tration ofradiolabeled estrogens in known estrogen
target tissues (uterus, oviduct, etc.). Subsequen-
tly, receptorproteins wereindeed found inrelatively
high concentrations in those tissues. The idea was
advanced that the simple presence or absence of
receptor in a cell or tissue was critical in determin-
ing response to a sex steroid (10). This view has
gradually changed subsequently. Certainly it is
clear that virtually all normal tissues contain gluco-
corticoid receptors (and probably sex steroid re-
ceptors too), although their concentration varies
between cells. The currently unanswered question
of mechanism is, therefore, what lies beyond the
receptor. Putting it another way, what mechanisms
account for the diverse tissue responses to cortico-
steroids, considering the fact that all or most cells
contain receptors for these steroids? Figures 1 and
2 show a model ofsteroid action which attempts to
point out some ofthe possible sites for this diversi-
ty of response.
Tissue culture systems have been particularly
useful in defining certain aspects of the actions of
glucocorticoids. The idea that such steroids act by
inducing enzymes indeed came from in vivo studies
(11, 12), but in HTC cells it was possible to show
that the hormones acted directly on the target cell
(2, 13). Subsequently an estimate of the limits of
the effects of glucocorticoids on cell proteins was
obtained by displaying HTC cell proteins by the
technique of two-dimensional gel isoelectric focus-
sing/electrophoresis. Comparison ofsteroid-treated
and untreated samples showed that some proteins
appeared to be induced while others were reduced
after steroid. The total number of altered peptide
spots was of the order of 20 (14). Isolation of cell
variants from the HTC parent line showed that
different steroid responses could be under separate
controls. That is, cells selected because oftheirlack
of one response did not necessarily lack all other
responses to glucocorticoids (15).
One of the classical cell responses to corticoste-
roids is lysis of thymus-derived lymphocytes (16).
This property has been exploited in tissue culture
systems to select steroid-resistant cells. Nearly all
the cells so isolated have shown an abnormality of
their steroid receptors (17-19). The usual pheno-
typeinsteroid-resistant mouselymphoid and human
leukemic cell lines has been loss or functional
abnormality ofreceptors forthe steroid. Ofparticu-
lar interest has been the finding that some human
leukemic cells with receptors still able to bind
steroid are nevertheless steroid-resistant. When
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FIGURE 2. Possible mechanisms of noncoordinate control of
multiple steroid-sensitive functions. This model assumes that
(1) all the functions investigated are effected through
steroid-receptor-chromatin interactions; (2) steroid enters
the cellbyfree diffusion; (3) there is no selective action atthe
nuclear membrane; and (4) the affinity ofreceptor for steroid
is identical, whether a single or many classes of receptor
exist. These assumptions may be false, but are made here to
focus attention on steroid-receptor interactions in the cell.
After entering the cell, steroid (S) binds to receptors (R). At
this level and beyond, several nonexclusive possibilities may
intervene: (1) There are two or more subsets ofreceptors for
the steroid (R1, R2, R3,... , Rn). These subsets vary onlyin
the facet of their surface which interacts with other cellular
sites. With respect to steroid affinity, molecular weight, pI,
etc., they closely resemble one another. The variation in the
nonsteroid binding surface between receptor subsets ac-
counts for their interaction with various chromatin sites,
resulting in specific cellular responses. Thus, SR1 might be
responsible for TATinduction and PDE suppression, SR2for
GS induction, SR3 for AIB inhibition, etc. (2) There exist, as
has been suggested in several steroid-sensitive systems,
intermediate proteins (A) between the steroid-receptor
complex and the DNA. These intermediaries could fulfil the
role ofprovidng multiple specificities by providing a variety
of sites capable ofrecognizing distinct DNA sites. (3) There
could be preferential maskingofregulatory sites onthe DNA
(curved lines). Thus, if 1, 2, 3,... , n are n genes controlled
by glucocorticoids, the shading on 2 and on the regulatory
end of n represents masking proteins preventing SR* (±A)
interaction with the genome. Finally, (4) there may be
regulatory loops, with control, either positive or negative,
exerted by the products of certain induced genes. This is
indicated by the arrows from RNA and protein on the right,
dicted backtowards the DNA. TakeninpartfromThompson,
et al. (27).
examined in broken-cell systems, however, the
receptors from these cells were found to be abnor-
mally labile (20). Cells such as these may account
for at least some classes of human receptor-
positive, steroid-resistant leukemia.
The fact that most cells contain corticosteroid
receptors and yet show a wide variety of specific
responses to the hormones at once announce the
likelihood of post-receptor controls. These may be
positive-acting, allowing or causing the steroid-
receptor complex to exert a particular intracellular
action, or negative, blocking a response or set of
101Table 1. Glucocorticoid-inducible peptides whose expression
has been suppressed in somatic cell hybrids.a
Peptide Cross(es)
Tyrosine aminotransferase Rat x rat, mouse, hu-
man, Chinese hamster
Tryptophan oxygenase Mouse x mouse
Alanine aminotransferase Rat x Chinese hamster
Growth hormone Rat x mouse
Glycerol-3-phosphate Rat x mouse
dehydrogenase
a Detailed references available elsewhere (21).
responses. Evidence for the latter kind of controls
comes from somatic cell hybrids. In a number of
crosses between cells responding to corticoids by
induction of a particular peptide with cells not so
responding, induction of the peptide has been lost
(Table 1). In the case of estrogen induction of
prolactin the same is true, and there we have
shown that the hybrid cells contain no translatable
prolactin mRNA (22). Thus, the control exerted
probably prevents the cell from accumulating the
relevant mRNA. Agents under test for toxicity
might alter cellular responses to steroids by caus-
ing altered receptor content or function or by
causing adaptive or mutational changes in the
receptor gene. They might also cause changes in
cellular regulatory machinery, producing abnormal
responses or lack of response to an otherwise
normal steroid-receptor unit.
Intercellular and Multihormonal
Effects
The interwoven intercellular interactions and
multiple layers of hormonal controls which are
currently the focus ofgreat attention in endocrinol-
ogy and cell biology behoove the toxicologist to be
aware of possible secondary and tertiary effects of
the agent he studies. Forexample, as stated above,
thymic lymphocytes are inhibited and even killed
by pharmacologic concentrations ofcorticosteroids.
Subsets of such "T-cells" function in the immune
system as "killer lymphocytes," or as helpers or
suppressors of B cells, the lymphocytes which
synthesize circulating immunoglobulins. Further-
more, the growth and proliferation of T-cells de-
pend on the production ofthymic cell growth factor
by other cells of the thymus (23). The synthesis of
this factor is inhibited by corticosteroids (24). Thus
the apparent effects of the corticosteroids on the
immune system could be radically altered by com-
pounds which themselves vary any ofseveral cell or
hormonal elements within that system. The inter-
dependence of corticosteroids and other hormones
has been well known for years (5, 25). One example
from recent research will serve to illustrate this
interdependence. GH cells are a tissue culture line
of rat pituitary adenoma cells. In these cells,
corticosteroids alone have only a slight inductive
effect on the production of growth hormone. When
thyroid hormone and corticosteroids are given
together, however, there is a marked synergism in
the production of growth hormone (26). The action
of the adrenal steroid is strongly modified by the
presence ofthe thyroid hormone. Diminished effect
of the steroids in certain systems following expo-
sure to toxic products could well come from second-
ary hormonal interactions.
Summary
In this article, I have briefly set forth some ofthe
factors upon which the function of adrencortical
hormones depends. These include delivery by the
circulatory system, binding proteins in the circula-
tion, metabolism of the hormones, intracellular
receptors and modifiers of cell response to the
steroid-receptor complex, cell-cell interactions, and
multihormonal interactions at the target cell. Con-
sideration of all these factors is necessary in ap-
praising the effect of potentially toxic materials on
corticosteroid function.
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